The AI Immunology & Inflammation Research Intelligence agent — pathway to patient.
A scientific research agent (not a chatbot, not a diagnostic tool) that discovers, connects, analyses, challenges and synthesises immunology & inflammation knowledge from authorized literature, databases, datasets and enterprise tools — to help you understand what is known, what is unknown, what may be true, what has failed and what to test next.
Twelve deeply-connected knowledge domains spanning the research lifecycle.
Rheumatoid arthritis, psoriasis & PsA, IBD (Crohn's, UC), lupus, atopic dermatitis, asthma, MS, vasculitis and other autoimmune & inflammatory diseases across organ systems.
Innate & adaptive immunity, T/B-cell biology, myeloid cells, the complement system, tolerance & autoimmunity, tissue-resident immunity and the inflammation resolution program.
TNF, IL-17/23, IL-6, JAK-STAT, type-I/II interferons, chemokine networks and inflammasomes — mechanism → biomarker → target → therapy → outcome, across diseases sharing pathways.
Immunogenomics (HLA, GWAS), single-cell & spatial immune profiling, cytometry, proteomics, autoantibody repertoires and the microbiome — connected across scales.
Human-genetic, functional and multi-omics evidence for immune targets — with tractability, pathway redundancy, infection/malignancy safety and prior failures clearly separated.
mAbs & bispecifics, JAK & small-molecule inhibitors, cytokine traps, cell therapies (CAR-Treg), tolerogenic approaches and repurposing across the discovery-to-development cascade.
Diagnostic, prognostic, predictive and PD biomarkers, disease endotypes and patient-stratification signatures that enable precision immunology — with validation and utility context.
Design, population, endpoints (ACR, PASI, clinical remission), biomarkers, comparators, results and adverse events — surfacing failed hypotheses and under-served endotypes.
Infection, reactivation (TB, HBV), malignancy, immunogenicity and injection/infusion reactions — the safety trade-offs intrinsic to modulating immunity.
Differential expression, cell-type deconvolution, trajectory & network analysis, causal inference and predictive modelling on authorized immunology datasets.
Reasons across Disease ↔ Gene ↔ Cell ↔ Cytokine ↔ Pathway ↔ Biomarker ↔ Target ↔ Biologic ↔ Trial ↔ Outcome, with every claim traceable to primary sources.
Finds conflicting findings, non-responder mechanisms, missing endotype biomarkers and poorly-validated targets — then frames testable hypotheses and experiments.
Surface novel, testable research directions and drug-repurposing leads across the whole ecosystem — not a single paper.
Integrate literature, omics, trials and real-world data into one traceable evidence graph so hidden connections become visible.
A built-in scientific critic tests for confounding, batch effects, power, publication bias, replication and prior failures.
Research questions, proposals, protocols, SAPs, reviews and manuscript scaffolds — never fabricating data, patients, stats or citations.
Statements are tagged so you always know their standing — and confidence is stated, never inflated. Citations, DOIs, PMIDs, dataset and trial IDs are drawn from primary sources; if a source can't be verified it says so. Immunology & Inflammation Genius is a research-intelligence system, not a substitute for a physician — it does not diagnose or treat individuals.
We use cookies to run Anxya Health and improve your experience. Choose how we may use them. Read our Cookie Policy, Privacy Policy and Terms.